Variant report
Variant | esv3342552 |
---|---|
Chromosome Location | chr4:132643807-132647277 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:73)
- CpG islands (count:427)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CCNT2 | chr4:132646067-132646366 | K562 | blood: | n/a | n/a |
2 | CHD2 | chr4:132646065-132646272 | Hela-S3 | cervix: | n/a | n/a |
3 | CHD2 | chr4:132646072-132646353 | GM12878 | blood: | n/a | n/a |
4 | E2F6 | chr4:132646712-132646865 | K562 | blood: | n/a | n/a |
5 | ESR1 | chr4:132646144-132646379 | T-47D | breast: | n/a | n/a |
6 | HEY1 | chr4:132646169-132646415 | K562 | blood: | n/a | n/a |
7 | HEY1 | chr4:132646146-132646336 | HepG2 | liver: | n/a | n/a |
8 | JUND | chr4:132646170-132646446 | A549 | lung: | n/a | n/a |
9 | MAX | chr4:132646236-132646273 | GM12878 | blood: | n/a | n/a |
10 | MAX | chr4:132646710-132646923 | K562 | blood: | n/a | n/a |
11 | MAX | chr4:132646753-132646855 | K562 | blood: | n/a | n/a |
12 | MAX | chr4:132646229-132646270 | Hela-S3 | cervix: | n/a | n/a |
13 | MAZ | chr4:132646241-132646260 | K562 | blood: | n/a | n/a |
14 | NRF1 | chr4:132646069-132646270 | H1-hESC | embryonic stem cell: | n/a | n/a |
15 | NRF1 | chr4:132646059-132646277 | GM12878 | blood: | n/a | n/a |
16 | NRF1 | chr4:132646152-132646327 | SK-N-SH | brain: | n/a | n/a |
17 | POLR2A | chr4:132646166-132646407 | Hela-S3 | cervix: | n/a | n/a |
18 | POLR2A | chr4:132646236-132646390 | MCF-7 | breast: | n/a | n/a |
19 | POLR2A | chr4:132646116-132646448 | A549 | lung: | n/a | n/a |
20 | POLR2A | chr4:132646187-132646332 | A549 | lung: | n/a | n/a |
21 | POLR2A | chr4:132646182-132646347 | GM12878 | blood: | n/a | n/a |
22 | POLR2A | chr4:132646200-132646289 | A549 | lung: | n/a | n/a |
23 | POLR2A | chr4:132646074-132646435 | Hela-S3 | cervix: | n/a | n/a |
24 | POLR2A | chr4:132646177-132646426 | MCF-7 | breast: | n/a | n/a |
25 | POLR2A | chr4:132646073-132646442 | Raji | blood: | n/a | n/a |
26 | POLR2A | chr4:132646183-132646335 | H1-hESC | embryonic stem cell: | n/a | n/a |
27 | POLR2A | chr4:132646069-132646433 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | POLR2A | chr4:132646233-132646409 | Hela-S3 | cervix: | n/a | n/a |
29 | POLR2A | chr4:132646156-132646314 | HCT-116 | colon: | n/a | n/a |
30 | POLR2A | chr4:132646235-132646437 | GM12878 | blood: | n/a | n/a |
31 | POLR2A | chr4:132646152-132646317 | HUVEC | blood vessel: | n/a | n/a |
32 | POLR2A | chr4:132646221-132646287 | GM12878 | blood: | n/a | n/a |
33 | POLR2A | chr4:132646112-132646399 | HepG2 | liver: | n/a | n/a |
34 | POLR2A | chr4:132646179-132646336 | Hela-S3 | cervix: | n/a | n/a |
35 | POLR2A | chr4:132646237-132646372 | MCF-7 | breast: | n/a | n/a |
36 | POLR2A | chr4:132646229-132646433 | HepG2 | liver: | n/a | n/a |
37 | POLR2A | chr4:132646131-132646532 | GM12878 | blood: | n/a | n/a |
38 | POLR2A | chr4:132646163-132646329 | A549 | lung: | n/a | n/a |
39 | POLR2A | chr4:132646194-132646311 | A549 | lung: | n/a | n/a |
40 | POLR2A | chr4:132646236-132646427 | IMR90 | lung: | n/a | n/a |
41 | POLR2A | chr4:132646074-132646393 | K562 | blood: | n/a | n/a |
42 | POLR2A | chr4:132646102-132646468 | SK-N-MC | brain: | n/a | n/a |
43 | POLR2A | chr4:132646118-132646541 | GM12892 | blood: | n/a | n/a |
44 | POLR2A | chr4:132646169-132646311 | H1-hESC | embryonic stem cell: | n/a | n/a |
45 | POLR2A | chr4:132646158-132646318 | HCT-116 | colon: | n/a | n/a |
46 | POLR2A | chr4:132646079-132646362 | K562 | blood: | n/a | n/a |
47 | POLR2A | chr4:132646197-132646293 | HepG2 | liver: | n/a | n/a |
48 | POLR2A | chr4:132646180-132646341 | HepG2 | liver: | n/a | n/a |
49 | POLR2A | chr4:132646230-132646458 | HUVEC | blood vessel: | n/a | n/a |
50 | POLR2A | chr4:132646077-132646438 | MCF10A-Er-Src | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:132643925-132643975 | HRE | kidney: | n/a |
2 | chr4:132644348-132644398 | ovcar-3 | ovarian: | n/a |
3 | chr4:132646574-132646624 | GM19239 | blood: | n/a |
4 | chr4:132643925-132643975 | GM12878 | blood: | n/a |
5 | chr4:132644348-132644398 | NHBE | bronchial: | n/a |
6 | chr4:132647023-132647073 | HCT-116 | colon: | n/a |
7 | chr4:132645884-132645934 | H1-hESC | embryonic stem cell: | embryo |
8 | chr4:132644348-132644398 | HCF | heart: | n/a |
9 | chr4:132647121-132647171 | HEK293 | kidney: | embryo |
10 | chr4:132647121-132647171 | MCF-7 | breast: | n/a |
11 | chr4:132646360-132646410 | HNPCEpiC | eye: | n/a |
12 | chr4:132643925-132643975 | SK-N-SH | brain: | n/a |
13 | chr4:132643925-132643975 | Caco-2 | colon: | n/a |
14 | chr4:132647023-132647073 | U87 | brain: | n/a |
15 | chr4:132644348-132644398 | AG10803 | skin: | n/a |
16 | chr4:132647121-132647171 | HCPEpiC | choroid plexus: | n/a |
17 | chr4:132647121-132647171 | HNPCEpiC | eye: | n/a |
18 | chr4:132647121-132647171 | ovcar-3 | ovarian: | n/a |
19 | chr4:132644348-132644398 | LNCaP | prostate: | n/a |
20 | chr4:132646574-132646624 | NHDF-neo | bronchial: | n/a |
21 | chr4:132644348-132644398 | SK-N-SH | brain: | n/a |
22 | chr4:132647121-132647171 | GM19239 | blood: | n/a |
23 | chr4:132646574-132646624 | SK-N-SH_RA | brain: | n/a |
24 | chr4:132645884-132645934 | NHBE | bronchial: | n/a |
25 | chr4:132646360-132646410 | BJ | skin: | n/a |
26 | chr4:132644348-132644398 | HEEpiC | esophagus: | n/a |
27 | chr4:132645884-132645934 | IMR90 | lung: | fetal |
28 | chr4:132645884-132645934 | HCT-116 | colon: | n/a |
29 | chr4:132646360-132646410 | HEK293 | kidney: | embryo |
30 | chr4:132646574-132646624 | GM12892 | blood: | n/a |
31 | chr4:132645884-132645934 | GM12891 | blood: | n/a |
32 | chr4:132646360-132646410 | ovcar-3 | ovarian: | n/a |
33 | chr4:132646360-132646410 | PrEC | prostate: | n/a |
34 | chr4:132643925-132643975 | SKMC | muscle: | n/a |
35 | chr4:132644348-132644398 | HepG2 | liver: | n/a |
36 | chr4:132646360-132646410 | NH-A | brain: | n/a |
37 | chr4:132646360-132646410 | HUVEC | blood vessel: | n/a |
38 | chr4:132646574-132646624 | SAEC | small airway: | n/a |
39 | chr4:132646574-132646624 | HEEpiC | esophagus: | n/a |
40 | chr4:132646360-132646410 | Hela-S3 | cervix: | n/a |
41 | chr4:132646574-132646624 | HRCEpiC | kidney: | n/a |
42 | chr4:132646574-132646624 | GM12891 | blood: | n/a |
43 | chr4:132643925-132643975 | Hepatocyte | liver: | n/a |
44 | chr4:132646360-132646410 | NHBE | bronchial: | n/a |
45 | chr4:132645884-132645934 | ECC-1 | luminal epithelium: | n/a |
46 | chr4:132643925-132643975 | AG10803 | skin: | n/a |
47 | chr4:132647121-132647171 | PFSK-1 | brain: | n/a |
48 | chr4:132643925-132643975 | PFSK-1 | brain: | n/a |
49 | chr4:132647023-132647073 | HEK293 | kidney: | embryo |
50 | chr4:132647121-132647171 | K562 | blood: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RN7SL205P | TF binding region |
RN7SL205P | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs192517558 | chr4:132643816-132643817 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs28868081 | chr4:132643837-132643838 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs545726013 | chr4:132643862-132643863 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs139499150 | chr4:132643870-132643871 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs564843078 | chr4:132643891-132643892 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs575207970 | chr4:132643897-132643898 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs544132156 | chr4:132643900-132643901 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs62317432 | chr4:132643909-132643910 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs185033577 | chr4:132643910-132643911 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs572700220 | chr4:132643913-132643914 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs147173653 | chr4:132643917-132643918 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs189018579 | chr4:132643931-132643932 | Weak transcription Flanking Active TSS Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs376739760 | chr4:132643933-132643934 | Weak transcription Flanking Active TSS Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs541246653 | chr4:132643939-132643940 | Weak transcription Flanking Active TSS Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs532441267 | chr4:132643953-132643954 | Weak transcription Flanking Active TSS Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs111410834 | chr4:132643966-132643967 | Weak transcription Flanking Active TSS Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs538239640 | chr4:132643969-132643970 | Weak transcription Flanking Active TSS Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs561076243 | chr4:132643980-132643981 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548336888 | chr4:132643984-132643985 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs529745106 | chr4:132643994-132643995 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs568726366 | chr4:132644017-132644018 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs10007559 | chr4:132644030-132644031 | Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs193171974 | chr4:132644031-132644032 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577530684 | chr4:132644045-132644046 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs113993454 | chr4:132644047-132644048 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558691549 | chr4:132644053-132644054 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575293846 | chr4:132644054-132644055 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs184639826 | chr4:132644063-132644064 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs560757670 | chr4:132644065-132644066 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs574655680 | chr4:132644076-132644077 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs540157996 | chr4:132644077-132644078 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs559880145 | chr4:132644080-132644081 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs189859472 | chr4:132644088-132644089 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs533390043 | chr4:132644100-132644101 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs111601772 | chr4:132644101-132644102 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs545846373 | chr4:132644119-132644120 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs146323909 | chr4:132644124-132644125 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs562993411 | chr4:132644127-132644128 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs180718345 | chr4:132644128-132644129 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs548545195 | chr4:132644138-132644139 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs183592214 | chr4:132644142-132644143 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs62317433 | chr4:132644145-132644146 | Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs10007668 | chr4:132644148-132644149 | Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs559000935 | chr4:132644152-132644153 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs556836811 | chr4:132644193-132644194 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs140424234 | chr4:132644198-132644199 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs142096127 | chr4:132644208-132644209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554519928 | chr4:132644234-132644235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs181807341 | chr4:132644235-132644236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs540095366 | chr4:132644237-132644238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Mental retardation | 17847001 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 18923514 | CNVD |
Autism | 22241247 | CNVD |
Mental retardation | 17901693 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Autism | 19492091 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:132643200-132644000 | Enhancers | GM12878-XiMat | blood |
2 | chr4:132643600-132644000 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr4:132643800-132646000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr4:132644000-132644200 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr4:132645800-132646800 | Active TSS | Rectal Mucosa Donor 31 | rectum |
6 | chr4:132646000-132646400 | Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr4:132646000-132646400 | Active TSS | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
8 | chr4:132646000-132646400 | Active TSS | Primary T helper cells fromperipheralblood | blood |
9 | chr4:132646000-132646400 | Active TSS | Primary T regulatory cells fromperipheralblood | blood |
10 | chr4:132646000-132646400 | Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
11 | chr4:132646000-132646400 | Active TSS | Ovary | ovary |
12 | chr4:132646000-132646400 | Active TSS | Stomach Smooth Muscle | stomach |
13 | chr4:132646000-132647000 | Active TSS | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr4:132646200-132646400 | ZNF genes & repeats | Gastric | stomach |
15 | chr4:132646200-132646400 | Active TSS | Right Ventricle | heart |
16 | chr4:132646200-132646600 | ZNF genes & repeats | HUES48 Cell Line | embryonic stem cell |